Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Parola

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Gut|October 17, 2019
Of FACT complex and oxidative stress response: a KEAP1/NRF2-dependent novel mechanism sustaining hepatocellular carcinoma progressionBeatrice Foglia, Maurizio Parola
Molecular Aspects of Medicine|December 6, 2023
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategiesMaurizio Parola, Massimo Pinzani
Best Practice & Research. Clinical Gastroenterology|April 19, 2011
Liver fibrogenic cellsStuart J Forbes, Maurizio Parola
Best Practice & Research. Clinical Gastroenterology|April 10, 2012
Stem cells in liver failureFrancesco P Russo, Maurizio Parola
Cytotherapy|January 18, 2011
Stem and progenitor cells in liver regeneration and repairFrancesco Paolo Russo, Maurizio Parola
Gut|April 15, 2017
SENP1 activity sustains cancer stem cell in hypoxic HCCAlice Conigliaro, Marco Tripodi, Maurizio Parola
Molecular Aspects of Medicine|November 21, 2007
Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenarioMaurizio Parola, Fabio Marra, Massimo Pinzani
Stem Cell Investigation|October 26, 2016
<i>In vivo</i> reprogramming of hepatic myofibroblasts into hepatocytes attenuates liver fibrosis: back to the future?Erica Novo, Stefania Cannito, Maurizio Parola
Advanced Drug Delivery Reviews|June 5, 2017
Therapeutic pro-fibrogenic signaling pathways in fibroblastsStefania Cannito, Erica Novo, Maurizio Parola
Clinical Science (London, England : 1979)|November 1, 2015
Pathogenesis of solute-free water retention in experimental ascitic cirrhosis: is vasopressin the only culprit?Giovanni Sansoè, Manuela Aragno, Raffaella Mastrocola, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Gut|October 17, 2019
Of FACT complex and oxidative stress response: a KEAP1/NRF2-dependent novel mechanism sustaining hepatocellular carcinoma progressionBeatrice Foglia, Maurizio Parola
Molecular Aspects of Medicine|December 6, 2023
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategiesMaurizio Parola, Massimo Pinzani
Best Practice & Research. Clinical Gastroenterology|April 19, 2011
Liver fibrogenic cellsStuart J Forbes, Maurizio Parola
Best Practice & Research. Clinical Gastroenterology|April 10, 2012
Stem cells in liver failureFrancesco P Russo, Maurizio Parola
Cytotherapy|January 18, 2011
Stem and progenitor cells in liver regeneration and repairFrancesco Paolo Russo, Maurizio Parola
Gut|April 15, 2017
SENP1 activity sustains cancer stem cell in hypoxic HCCAlice Conigliaro, Marco Tripodi, Maurizio Parola
Molecular Aspects of Medicine|November 21, 2007
Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenarioMaurizio Parola, Fabio Marra, Massimo Pinzani
Stem Cell Investigation|October 26, 2016
<i>In vivo</i> reprogramming of hepatic myofibroblasts into hepatocytes attenuates liver fibrosis: back to the future?Erica Novo, Stefania Cannito, Maurizio Parola
Advanced Drug Delivery Reviews|June 5, 2017
Therapeutic pro-fibrogenic signaling pathways in fibroblastsStefania Cannito, Erica Novo, Maurizio Parola
Clinical Science (London, England : 1979)|November 1, 2015
Pathogenesis of solute-free water retention in experimental ascitic cirrhosis: is vasopressin the only culprit?Giovanni Sansoè, Manuela Aragno, Raffaella Mastrocola, et al.
Pageof 10